Gut Health in Pregnancy: What Diet Can and Cannot Tell Us

Gut health in pregnancy is often discussed through sweeping claims about the microbiome, inflammation and a baby’s future health. Recent evidence offers a more measured picture. A Mediterranean-style prenatal diet was associated with less infant colic and eczema, while a small clinical report documented encouraging outcomes when hepatitis C was treated during pregnancy.

These findings concern different parts of digestive and liver health, and neither proves that changing the maternal microbiome produces a particular outcome. Together, however, they show why gut-related symptoms, diet quality, infection status and treatment response need to be considered separately rather than folded into one broad idea of “gut balance.”

Gut health in pregnancy extends beyond digestion

Pregnancy can change appetite, bowel habits, reflux, nausea and food tolerance. Hormonal shifts, altered gastrointestinal movement, supplements, medications and changes in eating patterns may all contribute. At the same time, the liver is central to metabolism and infection management, so digestive health during pregnancy is not limited to bloating or constipation.

This wider view matters when interpreting studies. Infant colic is described as a disorder of gut-brain interaction, but its causes remain poorly understood. Eczema is an inflammatory skin condition with genetic, immune and environmental influences. Hepatitis C is a blood-borne viral infection affecting the liver. These conditions may intersect with nutrition or immune biology, yet they are not interchangeable markers of maternal gut health.

Nor does an association involving infant symptoms reveal exactly what happened in the pregnant participant’s digestive system. Maternal diet can affect nutrient exposure, metabolism and immune signalling through several routes. Microbial pathways are plausible, but the recent diet study did not establish that the microbiome caused the observed differences.

Prenatal diet was associated with less colic and eczema

A 2026 study in JAMA Network Open examined prenatal diet and subsequent infant colic and eczema. This was a prospective observational cohort, not a randomised feeding trial. It drew on Project Viva, which recruited participants in early pregnancy in Eastern Massachusetts, and included 2,128 mother-child pairs overall. The reported analysis contained 1,324 pairs with both exposure and outcome information.

Diet was assessed through food-frequency questionnaires in early and mid-pregnancy. Researchers calculated Mediterranean Diet Scores and Dietary Inflammatory Index values, and examined consumption of foods commonly associated with allergy. Infant outcomes were based on maternal reports of colic symptoms and eczema diagnosis at a median age of 6.3 months.

A healthier Mediterranean-style dietary pattern during pregnancy was associated with lower risks of infant colic and eczema. Regular seafood intake was also linked with lower risk. This supports studying overall dietary patterns rather than searching for a single “gut-health food.” Mediterranean-style eating generally brings together plant foods, fibre-rich carbohydrates, unsaturated fats and seafood, but the supplied study information does not identify one component as the mechanism.

The design sets important limits. Observational research can detect associations, but it cannot show that the diet itself prevented either condition. People with different dietary patterns may also differ in health status, supplement use, income, environmental exposures or access to care. Food-frequency questionnaires introduce recall and measurement error, while parent-reported outcomes may be classified inconsistently. The cohort was recruited more than two decades ago in one US region, which may limit how well the results transfer to current and more diverse populations.

The practical interpretation is therefore modest. A broadly nutritious prenatal diet may be associated with favourable infant outcomes, but the study does not justify restrictive diets, microbiome testing or unproven supplements to prevent colic or eczema. Seafood findings also need to sit within established pregnancy guidance on species choice and contaminant exposure, rather than being treated as a recommendation to maximise intake without qualification.

Liver infection is another part of digestive health

Separate 2026 evidence in Clinical Infectious Diseases addressed hepatitis C treatment during pregnancy. McCrary and colleagues reported real-world use of the antiviral combination glecaprevir-pibrentasvir in 14 patients. Ten completed treatment, and all 10 achieved a virologic response by or at delivery. No maternal or neonatal safety concerns were observed in the report.

This is clinically encouraging because treating infection during pregnancy could benefit maternal liver health and potentially change how care is timed. It also provides early real-world information where the abstract states that clinical-trial and real-world data for this regimen had previously been absent. The report notes that guidelines endorse antenatal hepatitis C treatment following shared decision-making.

But this was a very small case series, not a randomised trial. Four of the 14 patients did not complete treatment, and outcomes from 10 treatment completers cannot establish uncommon risks or broad safety across different clinical circumstances. Larger studies with comparison groups and longer maternal and infant follow-up are needed. The result supports careful clinical consideration, not routine self-directed conclusions about medication safety.

The distinction between these two studies is useful. Diet research asks whether patterns of exposure correlate with later outcomes. Antiviral evidence asks whether a defined treatment appears effective and safe in a small clinical group. Both relate to digestive or liver health, but they carry different levels and types of uncertainty.

Symptoms and responses are more useful as patterns

Daily digestive symptoms rarely have one explanation. Constipation may move with hormonal changes, hydration, iron supplementation, activity or fibre intake. Nausea may affect meal composition and energy, while reflux can disrupt sleep. A food that seems problematic on one day may coincide with stress, medication timing or a broader symptom flare.

That is why isolated notes tend to be less informative than repeated observations. Recording digestion alongside sleep, energy, supplements, diet changes and cycle-related symptoms can help distinguish a recurring association from normal day-to-day variation. This principle also matters beyond pregnancy, particularly through perimenopause, when changing hormones may overlap with altered bowel patterns, sleep and appetite. A perimenopause symptom tracker can clarify how these signals cluster, while energy tracking can show whether digestive changes coincide with fatigue or disrupted recovery.

Digestive symptoms, diet tolerance and response to a supplement or treatment become more readable when they are logged consistently over weeks. This is the kind of pattern Tulsy is built to surface.

Sources: Medical Xpress.

This content is for informational and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease, and should not replace advice from a qualified healthcare professional.